A number of factors such as the surging aging female population, increasing prevalence of infertility cases, and soaring incidence of uterine malformations are expected to drive the female fertility and pregnancy rapid test market at a CAGR of 4.5% during the forecast period (2016–2022). Moreover, the rising adoption of at-home diagnostic devices and mounting awareness about pregnancy and fertility among females will also help the market in generating a revenue of $489.3 million by 2022.

Access Detailed Report - Female Fertility and Pregnancy Rapid Test Market Regional and Country Breakdown@ https://www.psmarketresearch.com/market-analysis/fertility-and-preg...

The market growth is primarily driven by the surging cases of infertility across the world, owing to unhealthy lifestyles, alcohol intake, and hormonal imbalance. According to the World Health Organization (WHO), infertility is a disease of the reproductive organ and defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. The disease can be found in either the male or female reproductive system. As per WHO, nearly 48 million couples and 186 million individuals are affected by infertility globally.

Furthermore, the increasing use of home-based diagnostic testing products, owing to the rising incidence of several diseases, will also facilitate the female fertility and pregnancy rapid test market growth in the foreseeable future. Patients are now shifting from laboratory tests to rapid test kits due to the cost-effectiveness and convenience offered by such products in home care settings. Besides, the usage of home-based pregnancy kits also helps in maintaining the privacy of females, who might not opt for laboratory tests.

According to P&S Intelligence, North America will account for the largest share in the female fertility and pregnancy rapid test market during the forecast period, due to the booming population of aging women in the region. The women of North America are increasingly experiencing heavy bleeding, uterus abnormalities, and indestructible miscarriages, which require fertility and pregnancy rapid testing products in abundance. Moreover, the soaring healthcare expenditure in the region will also augment the market growth in the coming years.

Therefore, the burgeoning population of aging females, escalating use of home-based diagnostic products, and the growing incidence of infertility will supplement the market growth in the foreseeable future.